A new pill called Kapidex, for chronic heartburn caused when excess stomach acid backs up into the esophagus, was cleared by the Food and Drug Administration.
Kapidex is a new version of Prevacid.
The new formulation releases the drug in two separate stages in order to spread out the dose more evenly.
Prevacid loses its proprietary patent in November 2009. Prevacid and drugs of its genre (proton pump inhibitors) are the best selling prescribed drugs. (Blogger’s note: Americans must have a lot of heartburn. Is there no remedy without drugs?)
Regulators took three months longer than scheduled to decide whether to approve the new medicine, dexlansoprazole. (Blogger’s note: Why?)